logo
logo

Alcanza Clinical Research acquires Kansas City Research Institute to enhance clinical research capabilities

May 01, 2024•over 1 year ago

Acquiring Company

Alcanza

Acquired Company

Kansas City Research Institute

MethuenKansas CityBiotechnologyHealth CareMedicalBiotechnologyHealth Care

Description

Alcanza Clinical Research, a mission-focused investigator site network, has completed the acquisition of Kansas City Research Institute (KCRI), a Phase II-IV clinical research site based in Kansas City, MO. This strategic acquisition enables Alcanza to offer more trial participation opportunities to underrepresented patient populations in the Midwest region, especially with a focus on therapeutic specializations in gastroenterology, gastrointestinal oncology, hepatology, and metabolic diseases.

Company Information

Company

Alcanza

Location

Methuen, Massachusetts, United States

About

Alcanza Clinical Research is a mission-focused investigator site network dedicated to reducing barriers to clinical research participation, especially in underrepresented patient populations. The network includes 16 dedicated research units and 16 additional sites integrated within specialty clinics, strategically located across the Southeast, Northeast, and Midwest regions of the United States. Alcanza supports studies across all trial phases and major therapeutic areas.

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed